Centers | ||
|
|
|
Therapeutic Accelerator Program (TAP) | FDA Oncology Center of Excellence Project Catalyst | TEST |
Test |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
info here |
Partnerships |
Events |
Jobs |
Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all Vanderbilt and GSK Partner to Develop Therapies to Treat ObesityVanderbilt University and GSK have entered into partnership to develop drugs to treat Obesity. GSK will provide funding support to Vanderbilt for three years. View all XenoTech / XenoGesis
View all |
No EVENTS for listing |
No Job Posts |
